Literature DB >> 18040049

Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1.

Lot de Witte1, Michael Bobardt, Udayan Chatterji, Gisèle Degeest, Guido David, Teunis B H Geijtenbeek, Philippe Gallay.   

Abstract

Dendritic cells (DCs) efficiently capture HIV-1 and mediate transmission to T cells, but the underlying molecular mechanism is still being debated. The C-type lectin DC-SIGN is important in HIV-1 transmission by DCs. However, various studies strongly suggest that another HIV-1 receptor on DCs is involved in the capture of HIV-1. Here we have identified syndecan-3 as a major HIV-1 attachment receptor on DCs. Syndecan-3 is a DC-specific heparan sulfate (HS) proteoglycan that captures HIV-1 through interaction with the HIV-1 envelope glycoprotein gp120. Syndecan-3 stabilizes the captured virus, enhances DC infection in cis, and promotes transmission to T cells. Removal of the HSs from the cell surface by heparinase III or by silencing syndecan-3 by siRNA partially inhibited HIV-1 transmission by immature DCs, whereas neutralizing both syndecan-3 and DC-SIGN completely abrogated HIV-1 capture and subsequent transmission. Thus, HIV-1 exploits both syndecan-3 and DC-SIGN to mediate HIV-1 transmission, and an effective microbicide should target both syndecan-3 and DC-SIGN on DCs to prevent transmission.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040049      PMCID: PMC2148312          DOI: 10.1073/pnas.0703747104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.

Authors:  Aymeric de Parseval; Michael D Bobardt; Anju Chatterji; Udayan Chatterji; John H Elder; Guido David; Susan Zolla-Pazner; Michael Farzan; Tun-Hou Lee; Philippe A Gallay
Journal:  J Biol Chem       Date:  2005-09-12       Impact factor: 5.157

2.  Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.

Authors:  Angela Granelli-Piperno; Alla Pritsker; Maggi Pack; Irina Shimeliovich; Jean-Francois Arrighi; Chae Gyu Park; Christine Trumpfheller; Vincent Piguet; Thomas M Moran; Ralph M Steinman
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

3.  Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells.

Authors:  Michael D Bobardt; Udayan Chatterji; Suganya Selvarajah; Bernadette Van der Schueren; Guido David; Bruce Kahn; Philippe A Gallay
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

4.  Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.

Authors:  Laura Burleigh; Pierre-Yves Lozach; Cécile Schiffer; Isabelle Staropoli; Valérie Pezo; Françoise Porrot; Bruno Canque; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Ali Amara
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells.

Authors:  Udayan Chatterji; Michael D Bobardt; Robyn Stanfield; Roger G Ptak; Luke A Pallansch; Priscilla A Ward; Maureen J Jones; Cheryl A Stoddart; Pietro Scalfaro; Jean-Maurice Dumont; Kamel Besseghir; Brigitte Rosenwirth; Philippe A Gallay
Journal:  J Biol Chem       Date:  2005-09-30       Impact factor: 5.157

6.  Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa.

Authors:  Kevin B Gurney; Julie Elliott; Hoorig Nassanian; Carol Song; Elizabeth Soilleux; Ian McGowan; Peter A Anton; Benhur Lee
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes.

Authors:  Cinzia Nobile; Caroline Petit; Arnaud Moris; Katharina Skrabal; Jean-Pierre Abastado; Fabrizio Mammano; Olivier Schwartz
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection.

Authors:  Rebecca D Wiley; Suryaram Gummuluru
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

9.  Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture.

Authors:  Bruce K Patterson; Alan Landay; Joan N Siegel; Zareefa Flener; Dennis Pessis; Antonio Chaviano; Robert C Bailey
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

10.  In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions.

Authors:  Marielle Cavrois; Jason Neidleman; Jason F Kreisberg; Warner C Greene
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

View more
  70 in total

1.  Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4(+) target cells.

Authors:  Amichai Yavlovich; Mathias Viard; Ming Zhou; Timothy D Veenstra; Ji Ming Wang; Wanghua Gong; Eliahu Heldman; Robert Blumenthal; Yossef Raviv
Journal:  Blood       Date:  2012-07-02       Impact factor: 22.113

Review 2.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

3.  HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.

Authors:  Thijs van Montfort; Dirk Eggink; Maikel Boot; Michael Tuen; Catarina E Hioe; Ben Berkhout; Rogier W Sanders
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

4.  TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

Authors:  Marein A W P de Jong; Lot de Witte; Menno J Oudhoff; Sonja I Gringhuis; Philippe Gallay; Teunis B H Geijtenbeek
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

5.  A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells.

Authors:  I Frank; H Stössel; A Gettie; S G Turville; J W Bess; J D Lifson; I Sivin; N Romani; M Robbiani
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

6.  Biology of HIV mucosal transmission.

Authors:  Li Wu
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

7.  Virological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cells.

Authors:  Ping Chen; Benjamin K Chen; Arevik Mosoian; Thomas Hays; Michael J Ross; Paul E Klotman; Mary E Klotman
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

8.  Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.

Authors:  Briana Nixon; Thomas Jandl; Ryan S Teller; Ekaterina Taneva; Yanhua Wang; Umadevi Nagaraja; Patrick F Kiser; Betsy C Herold
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

Review 9.  Dendritic cells and macrophages in the genitourinary tract.

Authors:  N Iijima; J M Thompson; A Iwasaki
Journal:  Mucosal Immunol       Date:  2008-09-10       Impact factor: 7.313

10.  PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection.

Authors:  Timothy M Hanley; Wendy Blay Puryear; Suryaram Gummuluru; Gregory A Viglianti
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.